carnitine

(redirected from Carnitine deficiency)
Also found in: Medical, Acronyms, Encyclopedia.
Related to Carnitine deficiency: L-carnitine

car·ni·tine

 (kär′nĭ-tēn′)
n.
A compound that functions in fatty acid metabolism by transporting fatty acids into mitochondria for energy production. It is naturally produced in the body and is present in many animal products, especially red meat. It is also sold as a dietary supplement for its purported health benefits.

[German Karnitin, from Karnin, a basic substance derived from meat, from Latin carō, carn-, flesh; see carnal.]

carnitine

(ˈkɑːnɪˌtaɪn)
n
a white betaine, C7H15NO3, found in the liver and required for transporting fatty acids from the cytosol into the mitochondria
Translations

carnitine

n carnitina
Mentioned in ?
References in periodicals archive ?
Getting back to carnitine as a cause of atherosclerosis, children with Primary Carnitine Deficiency experience life-threatening heart failure which is reversed by L-carnitine which restores its cardiac levels.
2-propyl-4-pentenoic acid), (b) carnitine deficiency, (c) drug-induced CoA deficiency, (d) hyperammonemia, (e) familial metabolic defects, and f) oxidative stress (6).
Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes: evidence for alterations in tissue carnitine transport.
1,2) The administration of carnitine is particularly important, since it prevents the accumulation of toxic metabolites, as well as the development of carnitine deficiency and its association morbidity.
Carnitine deficiency is rare, but parents and physicians need to be educated and informed about it.
Shug was convinced that carnitine deficiency was an underlying cause of some serious health problems, such as muscle disease, liver dysfunction, and growth and heart problems.
Myocardial function, energy provision, and carnitine deficiency in experimental uremia.
Carnitine deficiency or suboptimal carnitine status would presumably lead to decreased energy production, potentially resulting in fatigue.
Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts.
Expanded newborn screening identifies maternal primary carnitine deficiency.
Carnitine deficiency with hyperbilirubinemia, generalised skeletal muscle weakness and reactive hypoglycemia in a patient on long-term parenteral nutrition.
Sigma-Tau Pharmaceuticals produces Carnitor[R] (levocarnitine), a prescription form of levocarnitine available for the treatment of carnitine deficiency in metabolic disorders.

Full browser ?